Epitomee Medical Ltd (TLV:EPIT)
Israel
· Delayed Price · Currency is ILS · Price in ILA 737.70
+2.20 (0.30%)
At close: Dec 4, 2025
Epitomee Medical Market Cap
Epitomee Medical has a market cap or net worth of 220.07 million as of December 5, 2025. Its market cap has decreased by -22.87% in one year.
Market Cap
220.07M
Enterprise Value
173.62M
Revenue
n/a
Ranking
n/a
PE Ratio
199.53
Stock Price
737.70
Market Cap Chart
Since December 15, 2021, Epitomee Medical's market cap has decreased from 1.21B to 220.07M, a decrease of -81.75%. That is a compound annual growth rate of -34.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 220.07M | -18.74% |
| Dec 31, 2024 | 270.81M | 149.63% |
| Dec 31, 2023 | 108.48M | -67.89% |
| Dec 29, 2022 | 337.85M | -63.70% |
| Dec 30, 2021 | 930.82M | -22.80% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 103.27B |
| Danel (Adir Yeoshua) | 2.70B |
| Kamada | 1.32B |
| BrainsWay | 1.06B |
| Bait Bakfar | 1.05B |
| SofWave Medical | 1.01B |
| Ilex Medical | 718.16M |
| Novolog (Pharm-Up 1966) | 653.92M |